Evidence map›Paper›PMID 20069525›Full record

ArticleCurrent protocols in cytometry2010

Use of flow cytometric methods to quantify protein-protein interactions.

Levi L Blazer, David L Roman, Molly R Muxlow, Richard R Neubig

Abstract read
In one paragraph

Article in Current protocols in cytometry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Flow Cytometry: Impact on Early Drug Discovery.Journal of biomolecular screening · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Levi L BlazerDepartment of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan, USA.
David L Roman
Molly R Muxlow
Richard R Neubig

Funding

RAPID KINETICS OF A2 ADRENERGIC RECEPTOR ACTIVATIONR01GM039561 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NEUBIG, RICHARD R · 1989 to 2013
$7.4M
MICHIGAN CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008597 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN · 1996 to 2018
$5.0M
HTS for Small Molecule Modulators of RGS ProteinsF32GM076821 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROMAN, DAVID L · 2006 to 2007
$95k
NIGMS NIH HHS F32 GM076821NIGMS NIH HHS GM076821NIGMS NIH HHS GM39561NIGMS NIH HHS R01 GM039561NIGMS NIH HHS T32 GM00008597NIGMS NIH HHS T32 GM008597
6 · The paper itself

Abstract

A method is described for the quantitative analysis of protein-protein interactions using the flow cytometry protein interaction assay (FCPIA). This method is based upon immobilizing protein on a polystyrene bead, incubating these beads with a fluorescently labeled binding partner, and assessing the sample for bead-associated fluorescence in a flow cytometer. This method can be used to calculate protein-protein interaction affinities or to perform competition experiments with unlabeled binding partners or small molecules. Examples described in this protocol highlight the use of this assay in the quantification of the affinity of binding partners of the regulator of G-protein signaling protein, RGS19, in either a saturation or a competition format. An adaptation of this method that is compatible for high-throughput screening is also provided.

Indexed as

Biological AssayBiotinBiotinylationFlow CytometryHigh-Throughput Screening AssaysProtein BindingRGS ProteinsBiotinregulator of G-protein signalling 19RGS Proteins

Identifiers

PMID20069525
PMCPMC2849137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.